USPTO serial 79446209
BTL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BULLOFF, TOBY ELLEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with BTL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ryan D Artis
Ryan D Artis Riverside Law LLP175 Strafford AveSuite 100Wayne, PA 19087Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Non-medicated toiletry preparations; cosmetics and cosmetic preparations; beauty care cosmetics; facial creams; facial beauty masks; facial cleansing preparations; cosmetic preparations for skin care; cosmetic preparations for body care; cosmetic preparations for slimming purposes; hair care preparations; cosmetic preparations for the care of mouth and teeth; fragrances and perfumes; essential oils for fragrancing and cosmetic purposes; cleaning preparations, other than for personal use; cosmetics for animals | ACTIVE | — |
| 005 | Chemical preparations for medical purposes, namely for the treatment of skin diseases and disorders, eye conditions and disorders, gastro-intestinal diseases, cardiovascular diseases, hormonal disorders, infectious diseases, immune system related diseases and disorders, musculo-skeletal disorders, diseases and disorders of the central nervous system and peripheral nervous system and respiratory diseases; Biological preparations for medical purposes, namely for the treatment of skin diseases and disorders, eye conditions and disorders, gastro-intestinal diseases, cardiovascular diseases, hormonal disorders, infectious diseases,immune system related diseases and disorders, musculo-skeletal disorders, diseases and disorders of the central nervous system and peripheral nervous system and respiratory diseases; Biological preparations for veterinary purposes, namely for the treatment of skin diseases and disorders, eye conditions and disorders, gastro-intestinal diseases, cardiovascular diseases, hormonal disorders, infectious diseases, immune system related diseases and disorders, musculo-skeletal disorders, diseases and disorders of the central nervous system and peripheral nervous system and respiratory diseases; Pharmaceuticals, namely dermatological pharmaceutical products and preparations, ophthalmological preparations, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, cardiovascular pharmaceutical preparations, pharmaceutical preparations for the treatment of hormonal disorders, pharmaceutical products for the treatment of infectious diseases, pharmaceutical preparations for the treatment of immune system related diseases and disorders, pharmaceutical preparations for the treatment of musculo-skeletal disorders, pharmaceutical preparations for the central nervous system, pharmaceutical preparations for peripheral nervous system, pharmaceutical products for treating respiratory diseases; Medicines for animals, namely for the treatment of skin diseases and disorders, eye conditions and disorders, gastro-intestinal diseases, cardiovascular diseases, hormonal disorders, infectious diseases, immune system related diseases and disorders, musculo-skeletal disorders, diseases and disorders of the central nervous system and peripheral nervous system and respiratory diseases; Medicines for dental purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Dietary supplements; Dietetic preparations adapted for medical purposes; Sanitary preparations for medical use; Medicated cosmetics; Medicated shampoos; Medicated soaps; Medicated sunburn lotions; Medicated hair lotions; Medicated diaper rash lotions; Medicated lotions for treating dermatological conditions; Medicated dentifrices; Medicated hair growth stimulants; Medicated skin care preparations; Medical preparations for slimming purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 15, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 9, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 21, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 18, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 18, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 18, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 18, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 30, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 30, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 21, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 18, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 17, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 27, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 27, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 25, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Mar 19, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |